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ABSTRACT 
---------------------------------------------------------------------------------------------------------- 
DNA parallel clamps with a polypurine strand linked to a polypyrimidine Hoogsteen 
strand containing locked nucleic acids bind their corresponding polypyrimidine targets 
with high affinity.  
---------------------------------------------------------------------------------------------------------- 
 
Introduction.- Triplex-forming oligonucleotides (TFOs) constitute interesting DNA 
sequence-specific binders that have wide potential applications in diagnosis, gene 
analysis and therapy. Under experimental conditions, triplex formation can be used to 
extract and isolate specific nucleotide sequences [1], inhibit DNA transcription and 
replication [2], generate site-directed mutations [3], cleave DNA [4] or induce 
homologous recombination [5].  
In a classical DNA triplex, the triplex-forming oligonucleotide binds to a 
polypurine-polypyrimidine region of dsDNA in the major groove through specific 
hydrogen bonds. Depending on the orientation and base composition of this third strand, 
triplexes are classified as parallel or antiparallel. Homopyrimidine TFOs bind parallel to 
the duplex purine strand via Hoogsteen hydrogen bonds to form T·AT and C+·GC 
triplets, whereas purine-rich TFOs bind in an antiparallel orientation by reverse 
Hoogsteen bonding and form G·GC, A·AT and T·AT triplets [6].  
Because cytosine bases in a homopyrimidine TFO must be protonated at N3 to 
form C+·GC triplets, the formation of parallel triplexes requires acidic conditions and is 
thus extremely unstable at pH 7. Therefore, stabilization of the homopyrimidine TFOs 
at physiological conditions is of great importance in improving its biological potential 
and a great effort has been made to modify oligonucleotides to enhance triple helix 
stability [7]. 
In 1998, novel conformationally restricted nucleotide analogues known as 
locked nucleic acid (LNA) were described [8]. LNA nucleotides contain a methylene 
bridge that connects the 2’-oxygen of ribose with the 4’-carbon. This bridge results in a 
locked 3’-endo conformation, reducing the flexibility of the ribose and increasing the 
local organization of the phosphate backbone. This pre-organization is believed to 
increase the strength of base-stacking interaction [9]. Several studies demonstrate that 
LNAs have greater affinity for complementary DNA and RNA sequences [10]. 
The triplex-forming properties of oligonucleotides containing LNA in the 
Hoogsteen chain have been reported elsewhere [11]. Except Petersen and colleagues 
[11b], who studied an intramolecular dsDNA:LNA triplex, the remaining authors 
focused on adding a homopyrimidine LNA-modified TFO to an existing WC duplex. 
An alternative approach consists in the triple-helix formation of a pyrimidine 
RNA/DNA strand with a parallel-strand Hoogsteen hairpin duplex. Such parallel-
stranded hairpins were first described by Agrawal and Kandimalla [12] and have been 
reported to form triplex with greater thermal stability than conventional triplexes. In 
addition, the use of parallel clamps not only allows the possibility of forming triplexes 
with mRNA targets [1, 12] but also decreases the susceptibility of oligonucleotides to 
degradation by cellular nucleases [12, 13].  
In our experiments the homopyrimidine LNA-containing Hoogsteen strand and 
the natural homopurine WC strand are covalently attached by 5’-5’ internucleotide 
junctions, and the WC pyrimidine strand is added. The sequence was selected from a 
triplex studied by Xodo et al. [14] which we had also studied in the context of 8-
aminopurines substitutions [15]. We have previously shown that the presence of 2’-O-
methyl-RNA residues improves triplex formation [15c]. Here, we show that parallel 
clamps containing LNA residues at the Hoogsteen polypyrimidine strand bind to the 
corresponding polypyrimidine target strand via triple-helix formation with greater 
affinity than unmodified hairpins. 
 
Results and Discussion.- 1. Design of oligonucleotides. Oligonucleotides used 
in this study are listed in Table 1. Oligonucleotide sequences are based on a triplex 
characterized previously.14 Here, the polypyrimidine Hoogsteen strand was linked to the 
Watson-Crick (WC) polypurine strand (Figure 1). Clamps are formed by two chains of 
eleven bases connected by 5’-5’ through a tetrathymidine loop. Hairpin B22 is a control 
sequence that contains only the natural bases without modifications. Hairpin B22-T 
contains three LNA thymidine nucleotides and B22-C contains three 5’-Me-C-LNA 
bases. In addition, a hairpin bearing two T-LNA and three 5’-Me-C-LNA was prepared 
(B22-CT) to test whether the stabilizing properties of the two modifications are 
additive. 
To study the effect of the sugar type of the target on triplex stability, the 
polypyrimidine target strand was synthesized with either DNA or 2’-O-methyl-RNA 
backbone. A 2’-O-methyl-RNA strand was used as a nuclease-stable model for a natural 
RNA target. 
 
2. Thermal stability of the Hoogsteen parallel duplexes. First melting curves of 
clamps (B22, B22-T, B22-C and B22-CT) alone, in the absence of the polypyrimidine 
target, were recorded (Table 2). Depending on the pH we observed two different 
transitions. At pH 5 we observed a transition with 15% hyperchromicity at 260 nm that 
decreased in intensity at higher pH. This transition was assigned to the denaturation of 
the parallel duplex, as described previously [15, 16]. To confirm that this transition 
corresponds to the denaturation of the Hoogsteen parallel duplex to a random coil, all 
the melting curves were also recorded at 295 nm. In all cases we observed the presence 
of a melting curve with hypochromicity as expected for a parallel duplex. It has been 
established that the change of absorbance at 295 nm indicates the formation of a 
nucleic-acid structure that requires protonation / deprotonation of cytosines [17]. As 295 
nm corresponds to a negative peak of the differential spectrum between protonated and 
non-protonated cytosines, the melting profile recorded at 295 is expected to be inverted. 
On the other hand, the absence of hyperchromism or hypochromism at 295 nm seems to 
be a general phenomenon for many WC duplex transitions. 
At pH above 6, a new transition appears at higher temperatures. We suggest that 
at pH above 6 the structure rearranges and short intermolecular antiparallel duplexes can 
be formed with the central part of the oligonucleotides (like a 7mer duplex between -
AGGAGGA- and -TCCTCCT-). This effect is mainly observed in clamps carrying 
LNA modifications, probably because LNA can enhance hybridization of 
complementary sequences. These transitions are only observed at 260 nm. No 
transitions are observed at 295 nm which indicates the presence of an antiparallel 
Watson-Crick duplex. 
The melting temperatures for clamps carrying the LNA were much higher than 
those for the unmodified sequence (Table 2). At pH 5.0 the increase in melting 
temperature (Tm) is 24 ºC for B22-C and 22 ºC for B22-T. The B22-CT hairpin, with the 
highest LNA content, is the most stable especially at pH 5 (more than 40 ºC difference). 
These results show that LNA modifications in the polypyrimidine strand enhance the 
stability of parallel duplexes, and therefore the stability of Hoogsteen bonds. 
 3. Thermal stability of triplexes formed by parallel clamps and their DNA / RNA 
polypyrimidine target strands. In the presence of a polypyrimidine target strand (WC-
11mer or WC-11mer/2’-OMe) hairpins B22 and derivatives form stable triplexes with 
higher stability than the Hoogsteen parallel duplexes alone. 
The thermal stability as indicated by the Tm value of all triple helices is given in 
Tables 3 (for DNA target) and 4 (for RNA target). As in the case of hairpins, the 
melting curves for the triplexes were recorded at both 260 and 295 nm to ensure that 
changes corresponded to triplex-to-random-coil transition. 
Although the stability of all these triplexes decreased when the pH was raised 
(caused by a destabilization of Hoogsteen bond due to a lower proportion of C+) the 
transition was observed even at pH 7. 
In all cases the resulting triplexes showed single, cooperative melting transitions 
(sigmoidal curves) with a pH-dependent hyperchromicity (ranging from 15% to 30% 
when pH decreases from pH 7.0 to pH 5.0 for triplexes with the DNA target, and from 
10% to 30% in the case of triplexes with the RNA target. This single transition was 
observed at both 260 and 295 nm throughout the pH range studied, indicating that the 
Hoogsteen and WC hydrogen-bonded strands dissociate simultaneously and that the 
change of absorbance in the melting profile is due to triplex-to-random-coil transition as 
described for clamps carrying 8-aminopurines [15]. 
In all cases the triplexes formed by LNA-containing hairpins showed higher Tm 
values than the unmodified triplexes, especially when the target was an RNA strand. 
The increase in Tm is presented in parentheses next to the Tm data for each pH value. 
When the target was a DNA sequence, B22T and B22C hairpins stabilized the 
triplex to a similar extent with an increase in Tm of 8-12ºC relative to the unmodified 
triplex. For B22-CT, differences in parallel duplex stability relative to B22-C and B22-
T disappeared when the triplex was formed, except for pH 5, where B22-CT still 
showed a significant increase in Tm. 
RNA or DNA backbone composition is reported to have dramatic effects on 
triple helix stability [18]. To study such effects, a target RNA polypyrimidine strand 
was synthesized. 
Although the Tm for the triplex formed by the unmodified B22 hairpin and the 
RNA target is lower than that of the triplex formed with the DNA target, the LNA-
containing hairpins form a more stable triplex in the presence of complementary RNA 
strand. Previous studies showed that combination of RNA pyrimidine and DNA purine 
strands forms a highly stable triplex [18]. As LNA has a locked C3’-endo-sugar pucker 
it can be considered as an RNA analogue derivative. So, when a polypyrimidine target 
is an RNA strand and the Hoogsteen pyrimidine strand of the clamp contains LNA, the 
resulting triplex will contain this favourable combination. According to this, the B22-
CT, with a higher LNA content and the most A-like (RNA) geometry, would form the 
most stable triplex, which is consistent with our experimental data. 
 
 
Conclusions. 
We have shown that LNA-modified parallel clamps bind to their polypyrimidine target 
strands via triple-helix formation with greater affinity than hairpins containing only 
natural bases. In addition, the presence of LNA residues stabilizes the parallel duplex, as 
can be deduced from the Tm values of hairpins alone at pH 5.0. As LNA nucleotides 
have a C3’-endo sugar pucker, the backbone conformation seems to have a strong 
positive effect on triplex and parallel duplex structures. Triplex stabilization by LNA 
residues is even stronger when the polypyrimidine target strand is an RNA sequence. 
These results are relevant for the design of clamps for potential applications based on 
triplex formation such as triplex affinity capture [1] and antisense inhibition of gene 
expression [12].  
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Experimental Part 
 
General. Phosphoramidites and ancillary reagents used during oligonucleotide synthesis 
were from Applied Biosystems (PE Biosystems Hispania S.A., Spain). The rest of the 
chemicals were purchased from Aldrich, Sigma or Fluka (Sigma-Aldrich Química S.A., 
Spain). 
 
Oligonucleotide synthesis. Oligonucleotides were prepared on an automatic Applied 
Biosystems 3400 synthesizer using phosphoramidite chemistry on polystyrene solid 
support (LV200). 5’-5’-Parallel clamps were prepared in three steps. First, the 
pyrimidine part was assembled using the appropriate C, T, LNA-T and LNA-5’methyl-
C phosphoramidites. Longer oxidizing and coupling times were used with LNA 
monomers, as indicated by the manufacturer. The phosphoramidite of 5’-methyl-C-
LNA was dissolved in a acetonitrile / tetrahydrofuran (3:1) mixture. Second, four 
additional thymidine phosphoramidites were added. This tetranucleotide loop was used 
to connect the two strands. From there onward, synthesis was continued using reversed 
G and A phosphoramidite monomers generating a 5’-5’ phosphate bond. After the 
assembly of the desired sequence, oligonucleotides were deprotected and cleaved from 
the support with concentrated aqueous ammonia at 55 ºC overnight. Ammonia solutions 
were concentrated to dryness and the products were purified by reverse-phase HPLC. 
Oligonucleotides were synthesized on a 0.2 µmol scale without performing final 
detritylation to facilitate reverse-phase purification. All purified products (DMT on 
protocol) presented a major peak, which was collected. HPLC solutions were as 
follows: solvent A, 5% ACN in 0.1 M triethylammonium acetate pH 6.5; solvent B, 
70% ACN in 0.1 M triethylammonium acetate pH 6.5. Column Nucleosil C18, 250 x 8 
mm. A 20 min linear gradient from 15 to 80% B (DMT on) with a flow rate of 3 ml/ 
min was used. Finally oligonucleotide clamps were detritylated, desalted by NAP-10 
and quantified by measuring the absorbance at 260 nm. Their molar absorptivities were 
calculated assuming identical absorptivities for LNA and DNA monomeric nucleotides. 
Masses of the oligonucleotides were measured by MALDI-TOF-MS in negative mode 
recorded on a Perseptive Voyager DETMRP mass spectrometer, equipped with nitrogen 
laser at 337 nm using a 3ns pulse. The matrix used contained 2,4,6-
trihydroxyacetophenone (THAP, 10 mg/ml in acetonitrile/ water 1:1) and ammonium 
citrate (50 mg/ ml in water). Measured masses of the oligonucleotides (calculated 
masses for M): WC-11mer: 3194 (3194); WC-11mer/ 2’-O-Me: 3453 (3454); B22: 
7950 (7952); B22-T: 8028 (8036); B22-C: 8072 (8078); B22-CT: 8122 (8134). 
 
Thermal denaturation studies. Melting experiments were performed as follows. 
Solutions of equimolar amounts of hairpins with or without the target Watson–Crick 
pyrimidine strand were mixed in 0.1 M sodium phosphate/citric acid buffer (pH ranging 
from 5.0 to 7.0) containing 1 M NaCl, with a final duplex concentration of 2 µM. The 
solutions were heated to 90°C, allowed to cool slowly to room temperature, and stored 
at 4°C until UV was measured. Thermal melting curves were recorded at 260 and 295 
nm at a heating rate of 1ºC/min with a Jasco V-650 Elmer spectrophotometer. The 
melting temperatures (Tm) were determined at the maximum of the first derivative of the 
melting curve. Melting temperatures are an average of at least two independent 
measurements within ±1.0 ºC. 
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LEGENDS 
 
Fig. 1. A) Structure of the triplex studied, B) T.A.T and C+.G.C triads C) Structure of 
LNA-T and LNA-Me-C phosphoramidites used. 
 
Table 1. Oligonucleotide sequences used in this study.  
 
 
Name          Sequence a  
WC-11mer       5’ TCTCCTCCTTC 3’ 
WC-11mer/2’-OMe      5’ UCUCCUCCUUC 3’ 
B22        3’ AGAGGAGGAAG 5’- 5’ TTTT - CTTCCTCCTCT 3’ 
B22-T        3’ AGAGGAGGAAG 5’- 5’ TTTT - CTtCCtCCtCT 3’ 
B22-C        3’ AGAGGAGGAAG 5’- 5’ TTTT - CTTcCTcCTcT 3’ 
B22-CT       3’ AGAGGAGGAAG 5’- 5’ TTTT - CtTcCtCcTcT 3’ 
 
a Lower bold case letters t and c are LNA thymidine and LNA 5’-methylcytosine respectively. 
Underlined upper case letters U and C are 2’-O-methyl-RNA derivatives. 
 
 
 
Table 2. Melting temperatures (ºC) of transitions observed with B22 and derivatives 
alone, without target. Two transitions are observed. The first transition was observed at 
260 nm (hyperchromic) and 295 nm (hypochromic). The second transition was only 
observed at 260 nm (hyperchromic). 
 
hairpin pH 5 pH 5.5 pH 6 pH 6.5 pH 7 
B22 52 / -- -- / -- -- / 55 -- / 55 -- / 56 
B22-T 74 / -- 52 / --  40 / --  -- / 75 -- / 70  
B22-C 76 / --  55 / --  45 / --  -- / 77  -- / 75  
B22-CT >90 / --  64 / --  51 / --  -- / 80 -- / 80  
 
 
Table 3. Melting temperatures (ºC) for the triplexes formed by B22 and derivatives with 
the DNA target WC-11mer. One single transition is observed at 260 nm (hyperchromic) 
and 295 nm (hypochromic). 
 
 
hairpin target pH 5 pH 5.5 pH 6 pH 6.5 pH 7 
B22 WC-11mer 62  55 45 31 18 
B22-T WC-11mer 74 (+12)a 65 (+10) 53 (+8) 39 (+8) 28 (+10) 
B22-C WC-11mer 73 (+11) 63 (+8) 52 (+7) 40 (+9) 29 (+11) 
B22-CT WC-11mer 79 (+17) 64 (+9) 52 (+7) 39 (+8) 28 (+10) 
a
 Values in parenthesis indicates the ∆Tm relative to unmodified triplexes. All Tm values are calculated 
with the curves recorded at 260 nm. 
 
 
Table 4. Melting temperatures (ºC) for the triplexes formed by B22 and derivatives with 
the RNA target WC-11mer/2’-OMe. One single transition is observed at 260 nm 
(hyperchromic) and 295 nm (hypochromic). 
 
hairpin target pH 5 pH 5.5 pH 6 pH 6.5 pH 7 
B22 WC-11mer/2’-OMe 62 53 41 24 n.d. 
B22-T WC-11mer/2’-OMe 77 (+15)a 68 (+15) 56 (+15) 39 (+15) 25 
B22-C WC-11mer/2’-OMe 77 (+15) 67 (+14) 53 (+12) 40 (+16) 27 
B22-CT WC-11mer/2’-OMe 84 (+22) 73 (+20) 60 (+19) 44 (+20) 30 
a
 Values in parenthesis indicates the ∆Tm  relative to unmodified triplexes. All Tm values are calculated 
with the curves recorded at 260 nm. n. d. not detected. 
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